Search

Displaying results 9821 - 9830 of 10000 in total
  1. Drug

    Orziloben

    go.drugbank.com/drugs/DB21653
    Experimental

    Orziloben has a monoisotopic molecular weight of 222.13 Da.

  2. Drug

    Tegeprotafib

    go.drugbank.com/drugs/DB21665
    Experimental

    Tegeprotafib has a monoisotopic molecular weight of 326.04 Da.

  3. Drug

    Vamagloxistat

    go.drugbank.com/drugs/DB21666
    Experimental

    Vamagloxistat has a monoisotopic molecular weight of 371.11 Da.

  4. Drug

    Milpecitinib

    go.drugbank.com/drugs/DB21676
    Experimental

    Milpecitinib has a monoisotopic molecular weight of 380.13 Da.

  5. Drug

    Claziprotamide

    go.drugbank.com/drugs/DB21687
    Experimental

    Claziprotamide has a monoisotopic molecular weight of 374.13 Da.

  6. Drug

    Abivertinib

    go.drugbank.com/drugs/DB15327
    Investigational

    [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. … Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK).

  7. Drug

    RO-5045337

    go.drugbank.com/drugs/DB14793
    Investigational

    RO-5045337 is under investigation in clinical trial NCT01164033 (A Study of RO5045337 in Patients With Solid Tumors).

  8. Drug

    Tibulizumab

    go.drugbank.com/drugs/DB14848
    Investigational

    Tibulizumab is under investigation in clinical trial NCT03736772 (A Study of LY3090106 in Japanese and Caucasian Healthy Participants).

  9. Drug

    PF-06815345

    go.drugbank.com/drugs/DB14862
    Investigational

    PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in Healthy Subjects).

  10. Drug

    AZD-4877

    go.drugbank.com/drugs/DB11671
    Investigational

    AZD4877 has been used in trials studying the treatment of NHL, Tumors, Cancer, Lymphoma, and Neoplasms, among others.